MERS-Cov vaccine (Anhui Zhifei Longcom Biopharmaceutical/Institute of Microbiology Chinese Academy of Sciences)

N/A

Report date: 2025/03/20 15:28:36

Base Information

Drug NameMERS-Cov vaccine (Anhui Zhifei Longcom Biopharmaceutical/Institute of Microbiology Chinese Academy of Sciences)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant proteinVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesInstitute Of Microbiology Of Chinese Academy Of Sciences
China Registration ClassN/A

Develop Information

Active CompaniesAnhui Zhifei Longcom Biopharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCoronavirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A